Biomx
NYSE: PHGENess Ziona · Founded 2015 · Delaware corporation · 29 employees on LinkedIn · 9 known investors
Find your way into Biomx
17 people in our graph can introduce you to the Biomx team.
Sign up to see every warm intro you have to Biomx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biomx team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security. It targets field-proven products serving homeland security, critical infrastructure, border, transportation, and public safety needs within a Detection, Analysis, and Response operational chain.
Founders & leadership

Investors · 9
How we know: AMR Action Fund's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: SBI JI Innovation Advisory Ltd.'s portfolio page · Not right? Tell us
How we know: Seventure Partners's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$72.3M disclosed across 5 of 7 rounds · 2017–2026
▶$3.3MraisedJan 2026 · 1 investors · PharmaceuticalsRule 506(b)
- Jesse GoodmanDirector
- Alan MosesDirector
- Jonathan LeffDirector
- Jonathan SolomonExecutive Officer, Director
- Merav BassanExecutive Officer
- Gregory MerrilDirector
- Eddie WilliamsDirector
- Susan BlumDirector
- Russell GreigDirector
- Marina WolfsonExecutive Officer
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- Sales commissions
- $210K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$61.5MraisedApr 2024 · 34 investors · PharmaceuticalsRule 506(b)
- Jesse GoodmanDirector
- Assaf OronExecutive Officer
- Russell GreigDirector
- Edward WilliamsDirector
- Gregory MerrilDirector
- Marina WolfsonExecutive Officer
- Jonathan LeffDirector
- Jonathan SolomonExecutive Officer, Director
- Alan MosesDirector
- Avi GabayExecutive Officer
- Merav BassanExecutive Officer
- Offering amount
- $61.5M
- Amount sold
- $61.5M
- Sales commissions
- $1.4M
- Placement agents
- RBC Capital Markets, LLC, Laidlaw & Company (UK) Ltd.
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2023 · 10 investors · PharmaceuticalsRule 506(b)
- Russell GreigDirector
- Lynne SullivanDirector
- Assaf OronExecutive Officer
- Merav BassanExecutive Officer
- Alan MosesDirector
- Marina WolfsonExecutive Officer
- Jonathan SolomonExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $1.5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedJan 2022 · 1 investors · PharmaceuticalsRule 506(b)
- Jonas GrossmanDirector
- Lynne SullivanDirector
- Gbola AmusaDirector
- Marina WolfsonExecutive Officer
- Russell GreigDirector
- Alan MosesDirector
- Paul SekhriDirector
- Merav BassanExecutive Officer
- Jonathan Eitan SolomonExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3M
- Minimum investment
- $3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3MraisedOct 2021 · 1 investors · PharmaceuticalsRule 506(b)
- Jonathan Eitan SolomonExecutive Officer, Director
- Paul SekhriDirector
- Russell GreigDirector
- Jonas GrossmanDirector
- Lynne SullivanDirector
- Sailaja PuttaguntaExecutive Officer
- Marina WolfsonExecutive Officer
- Merav BassanExecutive Officer
- Alan MosesDirector
- Gbola AmusaDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $3M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Biomx.
Frequently asked questions
- What does Biomx do?
- BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security. It targets field-proven products serving homeland security, critical infrastructure, border, transportation, and public safety needs within a Detection, Analysis, and Response operational chain.
- Who are Biomx's investors?
- Biomx's investors include AMR Action Fund, Baruch Future Ventures, NSG Ventures, OrbiMed, SBI JI Innovation Advisory Ltd., Seventure Partners, 8VC, Deerfield Management Company and 1 more.
- How much funding has Biomx raised?
- Biomx has disclosed $72.3M raised across 5 of its 7 known rounds.
- Where is Biomx headquartered?
- Biomx is headquartered in Ness Ziona.







